Treating Late-life Depression

Learning Objectives

  1. List three challenges in geriatric psychopharmacology for depression
  2. Understand approach to initial evaluation of depression treatment options in older adults
  3. Identify strategies for medication and side effect counseling when treating depression in older adults

Olivia Okereke, MD, MS

Dr. Olivia I. Okereke is Director of Geriatric Psychiatry and Director (Research) of the Geriatric Psychiatry Clinical and Research Program in the Department of Psychiatry at Massachusetts General Hospital, Associate Professor of Psychiatry at Harvard Medical School, and Associate Professor in Epidemiology at the Harvard T. H. Chan School of Public Health (HSPH). Dr. Okereke is committed to research in late-life mental health and well-being. Her programmatic research goals are: (1) to employ epidemiologic research methods to identify modifiable risk factors (e.g., diet, lifestyle), as well as related biomarkers, involved in healthy mental aging and (2) to translate and apply knowledge gained into novel, effective strategies for prevention of major adverse mental aging outcomes, such as anxiety, depression and cognitive decline. Her program has been funded by numerous awards from the National Institutes of Health (NIH), Harvard Medical School, and research foundations.